Literature DB >> 11588161

Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons.

J Braz1, C Beaufour, A Coutaux, A L Epstein, F Cesselin, M Hamon, M Pohl.   

Abstract

Rheumatoid arthritis is characterized by erosive inflammation of the joints, new bone proliferation, and ankylosis, leading to severely reduced locomotion and intense chronic pain. In a model of this disease, adjuvant-induced polyarthritis in the rat, neurons involved in pain transmission and control undergo plastic changes, especially at the spinal level. These changes affect notably neurons that contain opioids, such as enkephalins deriving from preproenkephalin A (PA) precursor protein. Using recombinant herpes simplex virus containing rat PA cDNA, we enhanced enkephalin synthesis in sensory neurons of polyarthritic rats. This treatment markedly improved locomotion and reduced hyperalgesia. Furthermore, the progression of bone destruction slowed down, which is the most difficult target to reach in the treatment of patients suffering from arthritis. These data demonstrate the therapeutic efficacy of enkephalin overproduction in a model of systemic inflammatory and painful chronic disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588161      PMCID: PMC6763863     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  45 in total

1.  A paracrine paradigm for in vivo gene therapy in the central nervous system: treatment of chronic pain.

Authors:  A A Finegold; A J Mannes; M J Iadarola
Journal:  Hum Gene Ther       Date:  1999-05-01       Impact factor: 5.695

Review 2.  Herpes simplex virus latent infection in the nervous system.

Authors:  I Steiner; P G Kennedy
Journal:  J Neurovirol       Date:  1995-03       Impact factor: 2.643

3.  Met-enkephalin levels and opiate receptors in the spinal cord of chronic suffering rats.

Authors:  F Cesselin; J L Montastruc; C Gros; S Bourgoin; M Hamon
Journal:  Brain Res       Date:  1980-06-02       Impact factor: 3.252

4.  Met-enkephalin is preferentially transported into the peripheral processes of primary afferent fibres in both control and HSV1-driven proenkephalin A overexpressing rats.

Authors:  J Antunes bras; C Becker; S Bourgoin; M Lombard; F Cesselin; M Hamon; M Pohl
Journal:  Neuroscience       Date:  2001       Impact factor: 3.590

5.  Effect of mu-opioids morphine and buprenorphine on the development of adjuvant arthritis in rats.

Authors:  J S Walker; A K Chandler; J L Wilson; W Binder; R O Day
Journal:  Inflamm Res       Date:  1996-11       Impact factor: 4.575

6.  Comparative efficacy of expression of genes delivered to mouse sensory neurons with herpes virus vectors.

Authors:  G Davar; M F Kramer; D Garber; A L Roca; J K Andersen; W Bebrin; D M Coen; M Kosz-Vnenchak; D M Knipe; X O Breakefield
Journal:  J Comp Neurol       Date:  1994-01-01       Impact factor: 3.215

7.  Autoradiographic evidence of 125I-beta-endorphin binding sites in the articular cartilage of the rat.

Authors:  M T Castaño; M Freire-Garabal; M Giraldez; M J Núñez; A Belmonte; J Couceiro; J Jorge
Journal:  Life Sci       Date:  1991       Impact factor: 5.037

8.  Increase in substance P and CGRP, but not somatostatin content of innervating dorsal root ganglia in adjuvant monoarthritis in the rat.

Authors:  G D Smith; A J Harmar; D S McQueen; J R Seckl
Journal:  Neurosci Lett       Date:  1992-03-30       Impact factor: 3.046

9.  Effect of the peripherally selective kappa-opioid agonist, asimadoline, on adjuvant arthritis.

Authors:  W Binder; J S Walker
Journal:  Br J Pharmacol       Date:  1998-06       Impact factor: 8.739

10.  Long-term expression in sensory neurons in tissue culture from herpes simplex virus type 1 (HSV-1) promoters in an HSV-1-derived vector.

Authors:  R L Smith; A I Geller; K W Escudero; C L Wilcox
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

View more
  44 in total

1.  Adeno-associated viral transfer of opioid receptor gene to primary sensory neurons: a strategy to increase opioid antinociception.

Authors:  Y Xu; Y Gu; G-Y Xu; P Wu; G-W Li; L-Y M Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-28       Impact factor: 11.205

Review 2.  Gene therapy: novel treatments for polyneuropathy and chronic pain.

Authors:  Marina Mata; Joseph C Glorioso; David J Fink
Journal:  Curr Neurol Neurosci Rep       Date:  2004-01       Impact factor: 5.081

Review 3.  Herpes simplex virus-based vectors.

Authors:  Robin Lachmann
Journal:  Int J Exp Pathol       Date:  2004-10       Impact factor: 1.925

Review 4.  Gene therapy for the treatment of chronic peripheral nervous system pain.

Authors:  William F Goins; Justus B Cohen; Joseph C Glorioso
Journal:  Neurobiol Dis       Date:  2012-06-02       Impact factor: 5.996

5.  Immunological thresholds in neurological gene therapy: highly efficient elimination of transduced cells might be related to the specific formation of immunological synapses between T cells and virus-infected brain cells.

Authors:  Carlos Barcia; Christian Gerdes; Wei-Dong Xiong; Clare E Thomas; Chunyan Liu; Kurt M Kroeger; Maria G Castro; Pedro R Lowenstein
Journal:  Neuron Glia Biol       Date:  2006-11

Review 6.  Viral vector-based gene transfer for treatment of chronic pain.

Authors:  Shuanglin Hao; Marina Mata; David J Fink
Journal:  Int Anesthesiol Clin       Date:  2007

7.  Effects of transgene-mediated endomorphin-2 in inflammatory pain.

Authors:  Shuanglin Hao; Darren Wolfe; Joseph C Glorioso; Marina Mata; David J Fink
Journal:  Eur J Pain       Date:  2008-06-24       Impact factor: 3.931

Review 8.  Methods for gene transfer to the central nervous system.

Authors:  Boris Kantor; Rachel M Bailey; Keon Wimberly; Sahana N Kalburgi; Steven J Gray
Journal:  Adv Genet       Date:  2014       Impact factor: 1.944

Review 9.  HSV vector-mediated modification of primary nociceptor afferents: an approach to inhibit chronic pain.

Authors:  J R Goss; M S Gold; J C Glorioso
Journal:  Gene Ther       Date:  2009-04       Impact factor: 5.250

10.  Peripheral non-viral MIDGE vector-driven delivery of beta-endorphin in inflammatory pain.

Authors:  Halina Machelska; Matthias Schroff; Detlef Oswald; Waltraud Binder; Nicolle Sitte; Shaaban A Mousa; Heike L Rittner; Alexander Brack; Dominika Labuz; Melanie Busch; Burghardt Wittig; Michael Schäfer; Christoph Stein
Journal:  Mol Pain       Date:  2009-12-14       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.